Balance Sheet
Liabilities and Shareholders Equity
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Non-Current Assets (2017 - 2024)

KalVista Pharmaceuticals' Non-Current Assets history spans 10 years, with the latest figure at $8.8 million for Q4 2024.

  • For Q4 2024, Non-Current Assets changed N/A year-over-year to $8.8 million; the TTM value through Dec 2024 reached $35.7 million, changed N/A, while the annual FY2024 figure was $9.7 million, N/A changed from the prior year.
  • Non-Current Assets for Q4 2024 was $8.8 million at KalVista Pharmaceuticals, up from $8.6 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $10.5 million in Q3 2023 and bottomed at $3.4 million in Q4 2020.
  • The 4-year median for Non-Current Assets is $8.6 million (2024), against an average of $7.1 million.
  • The largest YoY upside for Non-Current Assets was 59.63% in 2020 against a maximum downside of 19.18% in 2020.
  • A 4-year view of Non-Current Assets shows it stood at $3.4 million in 2020, then increased by 9.79% to $3.7 million in 2021, then surged by 173.82% to $10.1 million in 2023, then fell by 12.82% to $8.8 million in 2024.
  • Per Business Quant, the three most recent readings for KALV's Non-Current Assets are $8.8 million (Q4 2024), $8.6 million (Q4 2024), and $8.6 million (Q3 2024).